Pharmaco-electroencephalography and pharmacokinetic-pharmacodynamic modeling in drug development: Focus on preclinical steps

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 24, Issue SUPPL. D, 2002, Pages 127-128

  Danhof, M ^a   Visser, S A G ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CLOBAZAM; FLUNITRAZEPAM; MIDAZOLAM; OXAZEPAM; PSYCHOTROPIC AGENT; TIAGABINE;

BIOASSAY; CONFERENCE PAPER; DRUG DEVELOPMENT; ELECTROENCEPHALOGRAM; FOURIER TRANSFORMATION; PHARMACODYNAMICS; PHARMACOKINETICS; ARTICLE; BIOLOGICAL MODEL; DRUG EFFECT; DRUG SCREENING; ELECTROENCEPHALOGRAPHY; HUMAN; METHODOLOGY; PHARMACEUTICS;

DRUG EVALUATION; ELECTROENCEPHALOGRAPHY; HUMANS; MODELS, BIOLOGICAL; TECHNOLOGY, PHARMACEUTICAL;

EID: 0036458046     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Breimer, D.D., Danhof, M. Relevance of the application of pharmacokinetic-pharmacodynamic modelling concepts in drug development. The "Wooden Shoe" paradigm. Clin Pharmacokinet 1997, 32: 259-67.
2. Van der Graaf, P.H., Danhof, M. Analysis of drug-receptor interactions in vivo: A new approach in pharmacodynamic modelling. Int J Clin Pharmacol Ther 1997, 35: 442-6.
3. 1 receptors. J Pharmacol Exp Ther 1997, 283: 809-16.
4. 1 receptor agonists in rats: Prediction of tissue-dependent efficacy in vivo. J Pharmacol Exp Ther 1999, 290: 702-9.
5. Cox, E.H., Kerbusch, T., Van der Graaf, P.H., Danhof, M. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: Correlation with the interaction at the mu-opioid receptor. J Pharmacol Exp Ther 1998, 284: 1095-103.
6. Garrido, M., Gubbens-Stibbe, J.M.. Tukker, H.J., Cox, E.H., Drabbe, J., von Freitag, J., Künzel, D., Ijzerman, A., Danhof, M., Van der Graaf, P.H. Pharmacokinetic-pharmacodynamic analysis of the EEG effect of alfentanil in rats following β-funaltrexamine-induced mu-opioid receptor knockdown in vivo. Pharm Res 2000, 17: 653-9.
7. Cox, E.H., Langemeijer, M.W.E., Gubbens-Stibbe, J.M., Muir, K.T., Danhof, M. The comparative pharmacodynamics of remifentanil and its metabolite, GR90291, in a rat EEG model. Anesthesiology 1999, 90: 535-44.
8. Tuk, B., van Oostenbruggen, M.F., Herben, V.M.M., Mandema. J.W., Danhof, M. Characterization of the pharmacodynamic interaction between parent drug and active metabolite in vivo: Midazolam and alpha-OH-midazolam. J Pharmacol Exp Ther 1999, 289: 1067-74.
9. Cleton, A., de Greef, H.J.M.M., Edelbroek, P.M., Voskuyl, R.A., Danhof, M. Application of a combined "effect compartment/indirect response model" to the central nervous system effect of tiagabine in the rat. J Pharmacokinet Biopharm 1999, 27: 301-23.
10. Cleton, A., de Greef, H.J.M.M., Edelbroek, P.M., Voskuyl, R.A., Danhof, M. Stereoselective central nervous system effects of the R-and S-isomers of the GABA uptake blocker N-(4,4-di-(3-methylthien-2-yl)but-3-enyl)nipecotic acid in the rat. Br J Pharmacol 1999, 128: 1651-8.
11. Visser, S.A.G., Smulders, C.J.G.M., Reijers, B.P.R., van der Graaf, P.H., Peletier, L.A., Danhof, M. Mechanism-based pharmacokinetic-pharmacodynamic modeling of the EEG effects of concentration-dependent hysteresis and biphasic EEG effects of alphaxalone in rats. J Pharmacol Exp Ther 2002, 302: 1158-67.
12. A receptor in vivo. J Pharmacol Exp Ther 2002, 303: 616-26.
13. A receptor modulators: In vitro/in vivo correlations. J Pharmacol Exp Ther, in press.
14. A receptor subtype selectivity in vivo. J Pharmacol Exp Ther, in press.